N-((1,1-dimethylethoxy)carbonyl)-beta-alanine → 1,1-dimethylethyl {3-[(2-{[({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)amino]carbonyl}-1H-indol-5-yl)amino]-3-oxopropyl}carbamate

HRID 1874825Notes

Reaction equation

HRID 1874825 reaction equation
FC(F)(F)C(O)=O.[NH2:8][C:9]1[CH:10]=[C:11]2[C:15](=[CH:16][CH:17]=1)[NH:14][C:13]([C:18]([NH:20][CH2:21][C:22]1[CH:27]=[CH:26][C:25]([Cl:28])=[C:24]([O:29][C:30]3[CH:35]=[C:34]([C:36]#[N:37])[CH:33]=[C:32]([Cl:38])[CH:31]=3)[C:23]=1[F:39])=[O:19])=[CH:12]2.[CH3:40][C:41]([O:44][C:45]([NH:47][CH2:48][CH2:49][C:50](O)=[O:51])=[O:46])([CH3:43])[CH3:42].CCN(C(C)C)C(C)C.O=C1N(P(Cl)(N2CCOC2=O)=O)CCO1>>[Cl:28][C:25]1[CH:26]=[CH:27][C:22]([CH2:21][NH:20][C:18]([C:13]2[NH:14][C:15]3[C:11]([CH:12]=2)=[CH:10][C:9]([NH:8][C:50](=[O:51])[CH2:49][CH2:48][NH:47][C:45](=[O:46])[O:44][C:41]([CH3:40])([CH3:42])[CH3:43])=[CH:17][CH:16]=3)=[O:19])=[C:23]([F:39])[C:24]=1[O:29][C:30]1[CH:35]=[C:34]([C:36]#[N:37])[CH:33]=[C:32]([Cl:38])[CH:31]=1

Participants

5

Reactant 4

HCID 76809N-((1,1-dimethylethoxy)carbonyl)-beta-alanineHCID 81531DiisopropylethylamineHCID 152842Bis(2-oxo-3-oxazolidinyl)phosphinic chlorideHCID 866448845-amino-N-({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-1H-indole-2-carboxamide trifluoroacetate

Product 1

HCID 866448851,1-dimethylethyl {3-[(2-{[({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)amino]carbonyl}-1H-indol-5-yl)amino]-3-oxopropyl}carbamate

Procedure

5-Amino-N-({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-1H-indole-2-carboxamide trifluoroacetate (0.100 g, 0.213 mmol) was treated with N-{[(1,1-dimethylethyl)oxy]carbonyl}-β-alanine (0.040 g, 0.213 mmol), DIPEA (0.19 mL, 1.07 mmol) and bis(2-oxo-3-oxazolidinyl)phosphinic chloride (0.163 g, 0.639 mmol) in a similar manner as in the general procedure described herein to afford crude 1,1-dimethylethyl {3-[(2-{[({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)amino]carbonyl}-1H-indol-5-yl)amino]-3-oxopropyl}carbamate as a yellow solid. This crude material (0.027 g, 0.042 mmol) was suspended in dichloromethane (1 mL) and treated with trifluoroacetic acid (0.25 mL, 3.24 mmol) at RT for 1 h. The solvent was evaporated and the residue was purified by Reverse-Phase HPLC (water/acetonitrile with 0.1% TFA) to give the title compound (0.017 g, 62%) as a white solid. 1H NMR (400 MHz, DMSO-d6): δ ppm 11.59 (s, 1H), 10.01 (s, 1H), 9.00 (s, 1H), 7.97 (s, 1H), 7.82 (s, 1H), 7.63-7.79 (m, 2H), 7.44-7.57 (m, 2 H), 7.31-7.44 (m, 1H), 7.22-7.31 (m, 1H), 7.11 (s, 1H), 4.57 (s, 2H), 2.94-3.19 (m, 2H), 2.62-2.77 (m, 2H). MS: m/z 540 (M+1).

Sources & evidence

ORD record
ord-bfc9a3cb7e4a4b7c8dd3e0f504f8f3ec
Source dataset
uspto-grants-2012_11
Patent number
US08304419B2

Reaction notes

Loading…